Top Markets
#1 Trillions Trillions +4,371.22%
#2 Ozapay Ozapay +37.63%
#3 UnifAI Network UnifAI Network +26.77%
#4 Aria.AI Aria.AI +21.95%
#5 Zano Zano +17.34%
#6 Osaka Protocol Osaka Protocol +14.21%
#7 StakeStone StakeStone +13.94%
#8 Vestra DAO Vestra DAO +11.91%
#9 River Pts River Pts +10.84%
#10 pippin pippin +10.64%
Coin of the day
Trillions Trillions
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Classement en actions #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Prix de l'action
$0.28545656
Capitalisation boursière
$4.50M
Changement (1 jour)
5.97%
Changement (1 an)
0.00%
Pays
FR
Échange Acticor Biotech SAS (ALACT)

Catégorie

Healthcare
Historique du prix de l'action pour Acticor Biotech SAS (ALACT)
Prix de clôture le plus élevé : $0.29 le 2024-12-01

Prix de clôture le plus bas : $7.56 le 2021-11-01
Historique du prix de l'action de Acticor Biotech SAS de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $36.74 -53.49%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.49 -11.91%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $737.00 9.61%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $297.72 51.37%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.95 -40.77%
AU